Ac Immune
(NASDAQ) ACIU
Ac Immune Financials at a Glance
Market Cap
$333.82M
Revenue (TTM)
$3.57M
Net Income (TTM)
$70.34M
EPS (TTM)
$-0.84
P/E Ratio
-3.91
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$3.31
Volume
1,814
Open
$3.35
Price
$3.31
Volume
1,814
Open
$3.35
Previous Close
$3.28
Daily Range
$3.27 - $3.40
52-Week Range
$1.45 - $4.00
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$3.31
Volume
1,814
Open
$3.35
Previous Close
$3.28
Daily Range
$3.27 - $3.40
52-Week Range
$1.45 - $4.00
ACIU News
Why AC Immune Stock Surged Today
Why AC Immune SA Is Imploding
ACIU: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ac Immune
Industry
Biotechnology
Sector
Health CareEmployees
122
CEO
Andrea Pfeifer, PhD
Website
www.acimmune.comHeadquarters
Lausanne, 1015, CH
ACIU Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-19%
Net Income Margin
-20%
Return on Equity
-94%
Return on Capital
-1%
Return on Assets
-46%
Earnings Yield
-25.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$333.82M
Shares Outstanding
101.77M
Volume
1.81K
Short Interest
0.00%
Avg. Volume
306.34K
Financials (TTM)
Gross Profit
$3.57M
Operating Income
$68.86M
EBITDA
$63.47M
Operating Cash Flow
$66.15M
Capital Expenditure
$859.54K
Free Cash Flow
$67.01M
Cash & ST Invst.
$91.52M
Total Debt
$4.55M
Ac Immune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$338.00K
-70.3%
Gross Profit
$338.00K
-70.3%
Gross Margin
100.00%
N/A
Market Cap
$333.82M
N/A
Market Cap/Employee
$2.51M
N/A
Employees
133
N/A
Net Income
$14.26M
+9.7%
EBITDA
$13.72M
+10.0%
Quarterly Fundamentals
Net Cash
$86.97M
-45.7%
Accounts Receivable
$681.77K
-38.0%
Inventory
$0.00
N/A
Long Term Debt
$3.69M
-16.1%
Short Term Debt
$852.97K
-16.9%
Return on Assets
-45.55%
N/A
Return on Invested Capital
-1.15%
N/A
Free Cash Flow
$16.55M
-383.3%
Operating Cash Flow
$16.45M
-377.2%